Landiolol Hydrochloride for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting: New Evidence From the PASCAL Trial

Study Questions:

Does landiolol (an ultrashort-acting beta-blocker) prevent atrial fibrillation (AF) after coronary artery bypass grafting (CABG)?